Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10072066 Methods and compositions for treatment of a beta thalessemia

Patent 10072066 was granted and assigned to Sangamo Therapeutics on September, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Sangamo Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100720660

Patent Inventor Names

Lei Zhang0

Pei-Qi Liu0

Andreas Reik0

Date of Patent

September 11, 2018

Patent Application Number

146118800

Date Filed

February 2, 2015

Patent Citations Received

‌

US Patent 11492646 Nuclease-mediated genome editing of primary cells

‌

US Patent 11535674 Bivalent bispecific antibody hybrid protein expression and preparation methods

‌

US Patent 11634732 Pharmaceutical compositions comprising gene-corrected primary cells

Patent Primary Examiner

‌

Yong D Pak

Patent abstract

Methods and compositions for treatment of a beta thalessemia are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10072066 Methods and compositions for treatment of a beta thalessemia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API